Latest filing published 03 Sept 2026 for Quest Diagnostics INC, €2.1M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
J. E. Davis is a declared insider of Quest Diagnostics Inc (chief executive), with filings sourced from SEC (Form 4). In total, 76 filings cover trades dated from 16 February 2016 to 1 September 2026.
No open-market purchase appears, only 22 sales worth €27.0M. Besides market trades, the filings include 49 share grants and 5 option exercises. Since January 2026: no purchases and 1 sale on the market.
Most recently, on 3 September 2026, the filings show an open-market sale worth €2.1M in Quest Diagnostics Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations